European Society for the Study of Coeliac Disease (ESsCD) 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 2: Management, Follow‐Up, and Complex Disease Courses
United European Gastroenterology Journal · 2026-03 · 14 (2)
DOI: 10.1002/ueg2.70195 ↗Kurz gefasst
Leitlinie in der Zeitschrift United European Gastroenterology Journal, online erschienen am 14.03.2026. Verfasst von Abdulbaqi Al-Toma und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, St Antonius Hospital, Nieuwegein, the Netherlands. Hauptthemen laut MEDLINE: Celiac Disease. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 383 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Since the publication of the first European Society for the Study of Coeliac Disease (ESsCD) guidelines in 2019, substantial advances have been made in understanding the management and complex disease courses of coeliac disease (CeD) in adults. These 2025 updated guidelines aim to integrate new evidence, refine management strategies, and promote a personalised and multidisciplinary approach to care.
Methods
The ESsCD convened a multidisciplinary panel of experts to revise the 2019 guidelines using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) framework. Evidence was appraised and graded according to the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology. Statements and recommendations were draughted within working groups and finalised through a structured Delphi consensus process.
Results
The updated guidelines are presented in two parts. Part 1 , which has already been published, addresses the diagnostic approach to CeD in adults, whereas Part 2 focuses on disease management, structured follow‐up, and the evaluation and treatment of persistent symptoms despite a gluten‐free diet or refractory disease. New or expanded sections include guidance on the safe inclusion of oats, use of low‐FODMAP diets in patients with persistent symptoms, management of exocrine pancreatic insufficiency, recognition of functional asplenia and related vaccination recommendations, and stratified bone‐health screening. The guidelines also discuss nutritional and psychosocial support, digital models of care, and structured transition from paediatric to adult services. Updated therapeutic strategies for refractory CeD are provided, including immunosuppressive and novel pharmacologic options.
Conclusions
These updated guidelines offer a comprehensive, evidence‐based framework for the management and follow‐up of adults with CeD. By integrating recent scientific advances with pragmatic, patient‐centred recommendations, they seek to optimise clinical outcomes, quality of life, and long‐term health in individuals with CeD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, St Antonius Hospital, Nieuwegein, the Netherlands.
- Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Medizinische Klinik für Gastroenterologie, Infektiologie und Rheumatologie, Berlin, Germany.
- Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy.
- Unit of Gastroenterology, Azienda Ospedale Università Padova, Padua, Italy.
- Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.
- Istituti Clinici Scientifici Maugeri IRCCS, Gastroenterology Unit of Pavia Institute, Pavia, Italy.
ORCID-Profile: Abdulbaqi Al-Toma, Federica Branchi, Annalisa Schiepatti, Isabella Rosato, Honoria Ocagli
Zitieren
APA
Al-Toma, A., Branchi, F., Zingone, F., Schiepatti, A., Malamut, G., Canova, C., Rosato, I., Ocagli, H., Trott, N., Elli, L., Popp, A., Gianfrani, C., Auricchio, R., Neefjes-Borst, A., Sanders, D. S., Cellier, C., Mulder, C. J., Bouma, G., Lundin, K. E. A., …, & Schumann, M. (2026). European Society for the Study of Coeliac Disease (ESsCD) 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 2: Management, Follow‐Up, and Complex Disease Courses. United European Gastroenterology Journal, 14(2). https://doi.org/10.1002/ueg2.70195
Vancouver
Al-Toma A, Branchi F, Zingone F, Schiepatti A, Malamut G, Canova C, et al. European Society for the Study of Coeliac Disease (ESsCD) 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 2: Management, Follow‐Up, and Complex Disease Courses. United European Gastroenterology Journal. 2026;14(2). doi:10.1002/ueg2.70195
BibTeX
@article{AlToma2026,
author = {Al-Toma, Abdulbaqi and Branchi, Federica and Zingone, Fabiana and Schiepatti, Annalisa and Malamut, Georgia and Canova, Cristina and Rosato, Isabella and Ocagli, Honoria and Trott, Nick and Elli, Luca and Popp, Alina and Gianfrani, Carmen and Auricchio, Renata and Neefjes-Borst, Andra and Sanders, David S and Cellier, Christophe and Mulder, Chris J and Bouma, Gerd and Lundin, Knut E A and Sollid, Ludvig M and Schumann, Michael},
title = {European Society for the Study of Coeliac Disease (ESsCD) 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 2: Management, Follow‐Up, and Complex Disease Courses},
journal = {United European Gastroenterology Journal},
year = {2026},
volume = {14},
number = {2},
doi = {10.1002/ueg2.70195}
}
EUVIMED